Quincy Bioscience is a biotechnology company based in Middleton, Wisconsin, that focuses on the discovery, development, and commercialization of novel technologies. Quincy Bioscience is set apart by its cutting-edge applications of apoaequorin which is breaking new ground with apoaequorin, originally discovered in jellyfish, now patented by Quincy Bioscience for use in a variety of products. Apoaequorin is manufactured in a cGMP compliant facility. The discovery and development of apoaequorin in 1962 earned the scientists responsible great acclaim. Quincy Bioscience is building on this work through its novel use of apoaequorin. Apoaequorin achieved self-affirmed GRAS status (generally recognized as safe) after an independent panel of expert scientists concluded that apoaequorin is safe for use in food products. Quincy Bioscience offers a competitive compensation package including: Health Insurance effective on first day of employment Dental, Vision, Life, Short-Term and Long-Term Disability Insurance Flex Spending 401(k) Paid Vacation
$239K sweet spot round size
2004
$239K
from investors over 1 rounds
Quincy Bioscience raised $239K on February 1, 2011